Cargando…
Stromal Response to Prostate Cancer: Nanotechnology-Based Detection of Thioredoxin-Interacting Protein Partners Distinguishes Prostate Cancer Associated Stroma from That of Benign Prostatic Hyperplasia
Histological staining of reactive stroma has been shown to be a predictor of biochemical recurrence in prostate cancer, however, molecular markers of the stromal response to prostate cancer have not yet been fully delineated. The objective of this study was to determine whether or not the stromal bi...
Autores principales: | Singer, Elizabeth, Linehan, Jennifer, Babilonia, Gail, Imam, S. Ashraf, Smith, David, Loera, Sofia, Wilson, Timothy, Smith, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675098/ https://www.ncbi.nlm.nih.gov/pubmed/23762225 http://dx.doi.org/10.1371/journal.pone.0060562 |
Ejemplares similares
-
Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer
por: Jedinak, Andrej, et al.
Publicado: (2015) -
DNA methylation biomarkers distinguishing early-stage prostate cancer from benign prostatic hyperplasia
por: Kim, Stephanie S., et al.
Publicado: (2023) -
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia
por: Kiebish, Michael A., et al.
Publicado: (2021) -
Rare Variant of Carcinoma Prostate Masquerading as Benign Prostatic Hyperplasia
por: Khanduri, Sachin, et al.
Publicado: (2019) -
Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)